Review Timeline | CrossMark Policy | ClinMed Features
logo
International Journal of

Blood Research and DisordersISSN: 2469-5696

Archive

 Open Access DOI:10.23937/2469-5696/1410024

Successful Treatment of a Primary Cervical Diffuse Large B-cell Lymphoma with Rituximab-CHOP Immunochemotherapy

Diaz De-La-Noval B, Hernandez Gutierrez A, Zapardiel I, De-Santiago Garcia J and Diestro Tejeda

Article Type: Case Report | First Published: August 30, 2016

The incidence of Non-Hodgkin's Lymphoma (NHL) has been increasing in recent decades, the prevalence of extranodal-NHL is about 30 to 50% of all NHL patients. Primary Large B-cell extranodal lymphoma of the cervix is a very rare disease, 0.008% of all cervical tumors. The Diffuse large B-cell lymphoma (DLBCL) is the most common extranodal lymphoid neoplasm in around 25% of all NHL....

 Open Access DOI:10.23937/2469-5696/1410023

Polycythemia Vera with High Erythropoietin Level: Case Report

Rami Nassabein, Mariam al khatib, Marie Helen Abbas, Marie youssef, Daniel Amer and Jaafar Wazni

Article Type: Case Report | First Published: August 30, 2016

Polycythemia Vera (PV) is a myeloproliferative disorder of bone marrow stem cells characterized by erythrocytosis. Elevated erythropoietin level strongly indicates secondary erythrocytosis and excludes PV diagnosis. However, patients with PV who co-present with Budd-Chiari syndrome (BCS) have been documented with elevated serum erythropoietin levels provided that JAK2 mutation is positive....

 Open Access DOI:10.23937/2469-5696/1410022

First Haploidentical Transplant in Peru in Pediatric Patient with Bilineal Leukemia

Mariela Del Carmen Moreno, Cinthia Palacios and Yessenia Cruz

Article Type: Case Report | First Published: August 01, 2016

Bilineal leukemia is a very rare health condition, especially in pediatric patients; it is associated with poor prognosis, even without uniformity therapeutic criteria. Hereby, we present a 4-year-old boy, who debuted as T-cell lymphoblastic lymphoma, he initially received treatment induction, which was unanswered, further studies showed evidence of being bilinear leukemia (T-AML M5). He continued the AML induction therapy followed by four consolidations, achieving CR....

 Open Access DOI:10.23937/2469-5696/1410021

Significance of sCD86 Levels in Acute Myelogenous Leukemia Patients: An Egyptian Study

Naglaa M Hassan, Nevin M Al-azhary and Marwa M Hussein

Article Type: Research Article | First Published: May 28, 2016

The aim of the study is to assess the level of soluble CD86 (sCD86) in patients with de novo AML and to compare them with a normal control group to determine any possible role with prognosis and clinical outcome, as the significance of sCD86 in hematologic malignancies is still controversial....

 Open Access DOI:10.23937/2469-5696/1410020

Chronic Use of Adalimumab as Potential Cause of Severe Thrombocytopenia in Psoriatic Arthritis Patient: The Need for Regular Monitoring of Cytopenias

Viviane Chaves Pereira, Karoline Honorato Costa and Leonardo Rodrigues de Oliveira

Article Type: Case Report | First Published: May 28, 2016

Although they are rare, severe hematologic adverse effects are described and may be fatal. The current study describes the case of a patient presenting psoriatic arthritis, and under prolonged treatment with adalimumab. His condition worsened due to severe acute thrombocytopenia and severe hemorrhagic manifestations. Adalimumab was considered to be the probable cause of the thrombocytopenia and, therefore, its use was discontinued. The treatment consisted of corticosteroids, human immunoglobulin...

Volume 3
Issue 1